Clinical trial · Interventional
Testing the Re-Engineered Hospital Discharge
NCT00252057CI-TRIAL-00026649completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine if the "Re-Engineered Discharge" will decrease rehospitalization rates and adverse events of patients leaving Boston Medical Center.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| All | Acute Lymphoblastic Leukemia | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Re-Engineered Hospital Discharge | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Re-engineered hospital discharge
- description
- Participants received the "Re-Engineered Hospital Discharge", a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call 2-4 days after discharge by a clinical pharmacist.
- interventionNames
- Behavioral: Re-Engineered Hospital Discharge
- type
- NO_INTERVENTION
- label
- Standard hospital discharge
- description
- Participants received the routine, standard hospital discharge.
Primary outcomes (1)
- measure
- Total Number of Rehospitalizations (Emergency Department Visits Plus Hospital Admissions) in the 30 Days After Discharge.
- timeFrame
- 30 days after discharge
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: The Project Director will meet with the subject to determine if the patient meets inclusion or exclusion criteria. Inclusion criteria include are patients who: 1. are over 18 years old; 2. are to be discharged to a community, non-institutionalized setting; 3. report that they desire to be hospitalized in the future if there is a clinical need; and 4. are admitted to Firm B of the BMC Inpatient Service. Exclusion Criteria: 1. admitted to non-general Medical services at BMC (e.g., orthopedic surgery, obstetrics and gynecology, otolaryngology, general surgery, or psychiatry); 2. requiring hospice, nursing home or other institutional settings upon discharge, 3. who die during the admission, 4. subjects who speak languages other than English; 5. those who indicate that they have no access to a telephone or unable to give a contact telephone number; and 6. those not competent to sign informed consent.
References
Publications (3)
- DERIVEDWoz S, Mitchell S, Hesko C, Paasche-Orlow M, Greenwald J, Chetty VK, O'Donnell J, Jack B. Gender as risk factor for 30 days post-discharge hospital utilisation: a secondary data analysis. BMJ Open. 2012 Apr 18;2(2):e000428. doi: 10.1136/bmjopen-2011-000428. Print 2012. PMID 22514241
- DERIVEDMitchell SE, Paasche-Orlow MK, Forsythe SR, Chetty VK, O'Donnell JK, Greenwald JL, Culpepper L, Jack BW. Post-discharge hospital utilization among adult medical inpatients with depressive symptoms. J Hosp Med. 2010 Sep;5(7):378-84. doi: 10.1002/jhm.673. PMID 20577971
- DERIVEDJack BW, Chetty VK, Anthony D, Greenwald JL, Sanchez GM, Johnson AE, Forsythe SR, O'Donnell JK, Paasche-Orlow MK, Manasseh C, Martin S, Culpepper L. A reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med. 2009 Feb 3;150(3):178-87. doi: 10.7326/0003-4819-150-3-200902030-00007. PMID 19189907